Steris STE
NYSE STE
$215.76 -2.68 (-1.23%)
As of: Sep 9, 2026 · 3:29 PM EDT

Steris (STE) Net Income towards Common Stockholders (2018 - 2026)

Steris (STE) posted Net Income towards Common Stockholders of $201.0 million for Q2 2026, down 8.76% on a QoQ basis from $220.3 million in Q1 2026, and up 12.92% year-over-year from $178.0 million in Q2 2025.

Analysis

Steris (STE) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends

Steris has reported Net Income towards Common Stockholders for 9 years, with the latest figure at $201.0 million in Q2 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 12.92% year-over-year to $201.0 million in Q2 2026; TTM through Jun 2026 was $808.1 million, a 24.63% increase from a year earlier, with the FY2026 full-year figure at $785.1 million, up 27.45% from the prior year.
  • Net Income towards Common Stockholders was $201.0 million for Q2 2026 at Steris, down from $220.3 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $220.3 million in Q1 2026, with the low at -$315.2 million in Q3 2022.
  • Average Net Income towards Common Stockholders over 5 years is $121.2 million, with a median of $145.8 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders plunged 552.76% in 2022, then surged 14670.86% in 2025.
  • Over 5 years, Net Income towards Common Stockholders stood at $123.3 million in 2022, then grew by 14.29% to $140.9 million in 2023, then gained by 22.88% to $173.2 million in 2024, then gained by 12.18% to $194.3 million in 2025, then rose by 3.45% to $201.0 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $201.0 million (Q2 2026), $220.3 million (Q1 2026), and $194.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 183.54 Bn 177.93 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 124.70 Bn 119.48 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.91 Bn 109.09 Bn 6.34 Bn 1.48 Bn
4 Stryker 105.72 Bn 102.25 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 907.00 Mn
6 Edwards Lifesciences 49.52 Bn 45.27 Bn 1.35 Bn 241.40 Mn
7 Alcon 33.89 Bn 32.43 Bn 1.68 Bn -
8 Dexcom 32.10 Bn 30.15 Bn 830.00 Mn 249.10 Mn
9 Steris 21.06 Bn 20.58 Bn 684.20 Mn 201.00 Mn
10 Zimmer Biomet Holdings 18.26 Bn 17.85 Bn 1.54 Bn 199.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 201.00 Mn
Mar 31, 2026 220.30 Mn
Dec 31, 2025 194.30 Mn
Sep 30, 2025 192.50 Mn
Jun 30, 2025 178.00 Mn
Mar 31, 2025 146.00 Mn
Dec 31, 2024 173.20 Mn
Sep 30, 2024 151.20 Mn
Jun 30, 2024 145.50 Mn
Mar 31, 2024 -1.00 Mn
Dec 31, 2023 140.95 Mn
Sep 30, 2023 116.35 Mn
Jun 30, 2023 123.79 Mn
Mar 31, 2023 186.96 Mn
Dec 31, 2022 123.33 Mn
Sep 30, 2022 -315.23 Mn
Jun 30, 2022 110.76 Mn
Mar 31, 2022 93.64 Mn
Dec 31, 2021 143.09 Mn
Sep 30, 2021 69.63 Mn